Riboflavin Family

CE-marked riboflavin formulations

Our scientifically developed family of CE marked riboflavin formulations—VibeX Xtra, VibeX Rapid, ParaCel, MedioCROSS® TE, MedioCROSS® M, MedioCROSS® D, and MedioCROSS® H—ensure rapid diffusion in individual, sterile syringes for all your cross-linking needs.

We are proud to offer multiple CE-marked riboflavin formulations, which have set the standard to produce the highest quality riboflavin since the introduction of corneal cross-linking.

Glaukos riboflavin formulations have been used in hundreds of thousands of treatments around the world.

Syringes of VibeX Xtra™, VibeX Rapid™, ParaCel™, MedioCROSS® TE, MedioCROSS® M.
Syringes of VibeX Xtra™, VibeX Rapid™, ParaCel™, MedioCROSS® TE, MedioCROSS® M.

A tradition of quality & excellence

  • Long-established riboflavin supply combining innovative science and research with German manufacturing excellence
  • CE-marked products available worldwide
  • Compliant with Annex V of EC-Directive 93/42/EEC
  • ISO 13485 certified manufacturer and facility
  • Produced in world-class clean room; sterilized using validated and monitored processes

Our riboflavin formulations have been specifically designed to address the following cross-linking protocols

Epithelium-off treatment of keratoconus and corneal ectasia

Trans-epithelial treatment of keratoconus and corneal ectasia

Intra-stromal applications in conjunction with LASIK (Lasik Xtra®)

Syringe of VibeX Rapid™.

Riboflavin

VibeX Rapid

Syringe of VibeX Rapid™.

CE-marked VibeX Rapid riboflavin is formulated to improve diffusion rates while decreasing corneal thinning. VibeX Rapid has a diffusion rate of twice that of standard riboflavin and is topically applied to the cornea after epithelium removal. UVA light from the KXL® system is then applied for cross-linking.

Syringe of VibeX Rapid™.

Technical Information

Formulation:

0.1% Riboflavin, Saline, HPMC

Procedure:

Cross-linking for keratoconus &
corneal ectasia

Application:

Epithelium-off

Syringe of VibeX Xtra™.

Riboflavin

VibeX Xtra

Syringe of VibeX Xtra™.

CE-marked VibeX Xtra riboflavin is formulated specifically for use during the Lasik Xtra® procedure. VibeX Xtra is applied directly to the stromal bed prior to replacing the flap following excimer laser ablation. Formulated in an isotonic solution, VibeX Xtra diffuses quickly to minimize flap exposure time and deliver the appropriate concentration of riboflavin for cross-linking. Once the flap has been repositioned over the cornea, UVA light from the KXL® system is applied to activate VibeX Xtra to restore biomechanical integrity to the cornea.

Syringe of VibeX Xtra™.

Technical Information

Formulation:

0.22% Riboflavin, Saline, Isotonic

Procedure:

Lasik Xtra

Application:

Stromal Bed

Syringe of ParaCel™.

Riboflavin

ParaCel

Syringe of ParaCel™.

CE-marked ParaCel is a 2-step trans-epithelial riboflavin specifically formulated for direct application on the intact epithelium. ParaCel’s higher concentration of riboflavin and proprietary formulation allows for fast penetration and diffusion into the corneal stroma.

Intact epithelium diminishes the effects of cross-linking when low-powered UVA devices are used. The KXL® system offers 45 mW/cm2 of power for effective cross-linking through the intact epithelium using ParaCel.

Syringe of ParaCel™.

Technical Information

Formulation:

0.25% Riboflavin, HPMC, BAC

Procedure:

Cross-linking for keratoconus &
corneal ectasia

Application:

Epithelium-on

MedioCROSS®

MedioCROSS®

Glaukos is also the exclusive distributor of MedioCROSS® riboflavin. Please contact us or click below for more information on our line of MedioCROSS® riboflavin formulations.

Download the Brochure
Dispenser of the MedioCROSS

We want to hear from you!

Please contact us to learn more about our cross-linking products and procedures.

Contact Us

"*" indicates required fields

This field is for validation purposes and should be left unchanged.

Intended Use

The KXL® System is intended for illuminating the cornea during corneal cross-linking procedures stabilizing cornea which have been weakened by disease or by refractive surgery.

Safety Information

The KXL® System is contraindicated where the corneal thickness, with epithelium, is less than < 375 microns, in corneal melting disorders, aphakic patients, pseudophakic patients without UV blocking lens implanted, pregnant and nursing women, and children. Possible risks may include corneal haze, delayed epithelial healing, corneal edema, stromal scarring, keratitis by infection and sterile infiltrates. For full information consult the directions for use.

Please Select Your Country

Continue